InsightsTraumatic brain injury leads at $1.5B with 25% CAGR, driven by high incidence (1.4-3M US cases annually). Pituitary tumor and metastatic brain tumor follow but are declining. GBM appears twice — recurrent ($0.38B) and primary ($0.35B) — together representing $0.73B with strong growth trajectories.